Survivin plays an important role in cancer development. We aim to show here that suppression of survivin expression or function by antisense and dominant-negative (DN) mutant can inhibit gastric cancer carcinogenesis and angiogenesis in vivo. Plasmid constructs expressing survivin antisense and DN mutant replacing the cysteine residue at amino acid 84 with alanine (Cys84Ala) were prepared and introduced into BCG-823 and MKN-45 gastric cancer cells to establish stable transfectants. We showed that both antisense and DN mutant stable transfectants exhibited abnormal morphology, with decreased cell growth and increased rate of spontaneous apoptosis and mitotic catastrophe. Furthermore, in nude mice xenografts, these cells exhibited decreased d...
Survivin is a member of the family of apoptosis inhibitory proteins with increased expression level ...
Survivin, a member of the inhibitor of apoptosis (IAP) family, is upregulated in multiple cancers in...
Despite the constant exposure to genomic insults that may lead to malignancy, cancer is surprisingly...
Background: Survivin, a novel antiapoptotic gene has been linked with tumor development and progress...
Esophageal squamous cell carcinoma ranks among one of the most frequent cause of cancer death in the...
Survivin was recently described as an apoptosis inhibitor. Its pathogenic role in gastric cancer is ...
Survivin is a novel member of the inhibitor of apoptosis family and determines the susceptibility of...
Background & Aims: Reactivation of survivin expression is involved in carcinogenesis and angiogenesi...
Survivin is highly expressed in most human tumors and fetal tissue, and absent in terminally differe...
Esophageal cancer (EC) is the eighth most prevalent cancer and the sixth leading cause of cancer-rel...
Survivin, a member of the inhibitor of apoptosis protein (IAP) family, is detected in most common hu...
Survivin, a 16.5 kDa tumor associated antigen, is the smallest member of the inhibitor of apoptosis ...
PURPOSE: Molecular antagonists of the inhibitor of apoptosis protein survivin have shown promise as ...
Survivin is an antiapoptotic protein highly expressed in malignant cells that confers resistance to ...
Abstract Background Survivin is a member of the inhibitor-of-apoptosis (IAP) family which is widely ...
Survivin is a member of the family of apoptosis inhibitory proteins with increased expression level ...
Survivin, a member of the inhibitor of apoptosis (IAP) family, is upregulated in multiple cancers in...
Despite the constant exposure to genomic insults that may lead to malignancy, cancer is surprisingly...
Background: Survivin, a novel antiapoptotic gene has been linked with tumor development and progress...
Esophageal squamous cell carcinoma ranks among one of the most frequent cause of cancer death in the...
Survivin was recently described as an apoptosis inhibitor. Its pathogenic role in gastric cancer is ...
Survivin is a novel member of the inhibitor of apoptosis family and determines the susceptibility of...
Background & Aims: Reactivation of survivin expression is involved in carcinogenesis and angiogenesi...
Survivin is highly expressed in most human tumors and fetal tissue, and absent in terminally differe...
Esophageal cancer (EC) is the eighth most prevalent cancer and the sixth leading cause of cancer-rel...
Survivin, a member of the inhibitor of apoptosis protein (IAP) family, is detected in most common hu...
Survivin, a 16.5 kDa tumor associated antigen, is the smallest member of the inhibitor of apoptosis ...
PURPOSE: Molecular antagonists of the inhibitor of apoptosis protein survivin have shown promise as ...
Survivin is an antiapoptotic protein highly expressed in malignant cells that confers resistance to ...
Abstract Background Survivin is a member of the inhibitor-of-apoptosis (IAP) family which is widely ...
Survivin is a member of the family of apoptosis inhibitory proteins with increased expression level ...
Survivin, a member of the inhibitor of apoptosis (IAP) family, is upregulated in multiple cancers in...
Despite the constant exposure to genomic insults that may lead to malignancy, cancer is surprisingly...